G 409 (Propafenone Hydrochloride Extended-Release 325 mg)
Pill with imprint G 409 is White, Capsule-shape and has been identified as Propafenone hydrochloride extended-release 325 mg. It is supplied by Glenmark Pharmaceuticals Inc., USA.
Propafenone is used in the treatment of atrial fibrillation; atrial flutter; wolff-parkinson-white syndrome; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 325 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for G 409
Propafenone hydrochloride extended-release
- Imprint:
- G 409
- Strength:
- 325 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Glenmark Pharmaceuticals Inc., USA
- Manufacturer:
- Glenmark Pharmaceuticals Limited
- National Drug Code (NDC):
- 68462-0409
More about propafenone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 50 Reviews – Add your own review/rating
- Drug class: group I antiarrhythmics
Consumer resources
- Propafenone
- Propafenone Tablets
- Propafenone Sustained-Release Capsules
- Propafenone (Advanced Reading)
Other brands: Rythmol, Rythmol SR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
